| 摘要: |
| ［摘要］ 原发性高血压是心脑血管疾病的危险因素，CD4+ T细胞诱导的炎症免疫反应是其重要发病机制。近年来，有关CD4+ T淋巴细胞亚群的研究不断取得新进展。该文就CD4+ T淋巴细胞亚群在原发性高血压中作用的研究进展进行综述。 |
| 关键词: 原发性高血压病 CD4+ T淋巴细胞亚群 炎症免疫反应 |
| DOI：10.3969/j.issn.1674-3806.2016.11.27 |
| 分类号:R 544.1 |
| 基金项目:广西自然科学基金资助项目（编号:2013GXNSFAA019265）；广西医疗卫生重点科研课题（编号:重2011119） |
|
| Research progress of CD4+ T lymphocyte subsets in primary hypertension |
|
YANG Zi-cong, SHI Ying, LIU Ling
|
|
Department of Cardiology, the People′s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
|
| Abstract: |
| ［Abstract］ Essential hypertension is a risk factor for cardiovascular disease. Immuno-inflammatory response induced by CD4+ T cells is an important pathogenic mechanism for primary hypertension. Recently, the research of CD4+ T lymphocyte subsets has made continuous new progress. In this paper, we review the research progress of CD4+ T lymphocyte subsets in primary hypertension. |
| Key words: Essential hypertension（EH） CD4+ T lymphocyte subsets Immuno-inflammatory response |
